Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence
Xianwen Zhang, Yang Liu, Jianying Liu, et al.
Cell (2021) Vol. 184, Iss. 8, pp. 2229-2238.e13
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19
Jiantao Zhang, Amara Ejikemeuwa, Volodymyr Gerzanich, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 109
Accelerating antiviral drug discovery: lessons from COVID-19
Annette von Delft, Matthew D. Hall, Ann D. Kwong, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 585-603
Open Access | Times Cited: 100
A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
Yang Liu, Xianwen Zhang, Jianying Liu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 77
SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle
Kshitiz Walia, Abhishek Sharma, Sankalita Paul, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Genetic Conservation and Diversity of SARS‐CoV‐2 Envelope Gene Across Variants of Concern
Baoming Liu, Qiaobin Yao, Ruth Cruz‐Cosme, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Closed Access | Times Cited: 8
Replication and single-cycle delivery of SARS-CoV-2 replicons
Inna Ricardo-Lax, Joseph M. Luna, Tran Thi Nhu Thao, et al.
Science (2021) Vol. 374, Iss. 6571, pp. 1099-1106
Open Access | Times Cited: 70
Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies
Qi Xiang, Linhao Li, Jie Wu, et al.
Microbiological Research (2022) Vol. 258, pp. 126993-126993
Open Access | Times Cited: 46
SARS-COV-2 viroporins activate the NLRP3-inflammasome by the mitochondrial permeability transition pore
Joseph W. Guarnieri, Alessia Angelin, Deborah G. Murdock, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Marine Natural Products as Leads against SARS-CoV-2 Infection
Bhuwan K. Chhetri, Philip R. Tedbury, Anne Marie Sweeney-Jones, et al.
Journal of Natural Products (2022) Vol. 85, Iss. 3, pp. 657-665
Open Access | Times Cited: 29
ER-export and ARFRP1/AP-1–dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication
Guy Pearson, Harriet V Mears, Malgorzata Broncel, et al.
Science Advances (2024) Vol. 10, Iss. 14
Open Access | Times Cited: 8
An optimized high-throughput SARS-CoV-2 dual reporter trans-complementation system for antiviral screening in vitro and in vivo
Yingjian Li, Xue Tan, Jikai Deng, et al.
Virologica Sinica (2024) Vol. 39, Iss. 3, pp. 447-458
Open Access | Times Cited: 7
SARS-CoV-2 ORF3a Protein as a Therapeutic Target against COVID-19 and Long-Term Post-Infection Effects
Jiantao Zhang, Kellie Hom, Chen‐Yu Zhang, et al.
Pathogens (2024) Vol. 13, Iss. 1, pp. 75-75
Open Access | Times Cited: 6
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
Yeqing Sun, Weijin Huang, Hongyu Xiang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 554-554
Open Access | Times Cited: 6
A novel transcription and replication-competent virus-like particles system modelling the Nipah virus life cycle
Yulong Wang, Linjin Fan, Pengfei Ye, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
Matthew D. Hall, James M. Anderson, Annaliesa S. Anderson, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. Supplement_1, pp. S1-S21
Open Access | Times Cited: 41
Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories
Johnny R. Malicoat, Senthamizharasi Manivasagam, Sonia Zúñiga, et al.
Journal of Virology (2021) Vol. 96, Iss. 3
Open Access | Times Cited: 36
Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets
Jiantao Zhang, Qi Li, Ruth S. Cruz Cosme, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 27
Reverse genetic systems of SARS-CoV-2 for antiviral research
Chaitanya Kurhade, Xuping Xie, Pei‐Yong Shi
Antiviral Research (2022) Vol. 210, pp. 105486-105486
Open Access | Times Cited: 24
Genetic variety of ORF3a shapes SARS‐CoV‐2 fitness through modulation of lipid droplet
Weili Wang, Yafei Qu, Xin Wang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 14
Rapid Proliferation of Pandemic Research: Implications for Dual-Use Risks
Sriharshita Musunuri, Jonas B. Sandbrink, Joshua Teperowski Monrad, et al.
mBio (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 31
Stable Cell Clones Harboring Self-Replicating SARS-CoV-2 RNAs for Drug Screen
Shufeng Liu, Chao‐Kai Chou, Wells W. Wu, et al.
Journal of Virology (2022) Vol. 96, Iss. 6
Open Access | Times Cited: 22
Reverse genetics systems for SARS-CoV-2: Development and applications
Hou-Li Cai, Yao‐Wei Huang
Virologica Sinica (2023) Vol. 38, Iss. 6, pp. 837-850
Open Access | Times Cited: 13
Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells
Koya Miura, Youichi Suzuki, Kotaro Ishida, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 13
Cryo-electron tomography of viral infection — from applications to biosafety
Liv Zimmermann, Petr Chlanda
Current Opinion in Virology (2023) Vol. 61, pp. 101338-101338
Open Access | Times Cited: 11
A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication
Yuzheng Zhou, Zongpeng Chen, Sijie Liu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top